Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD
Hepatology
.
2024 May 1;79(5):E130-E131.
doi: 10.1097/HEP.0000000000000755.
Epub 2024 Jan 22.
Authors
Oumarou Nabi
1
2
,
Nathanaël Lapidus
2
,
Jerome Boursier
3
4
,
Victor de Ledinghen
5
,
Jean-Michel Petit
6
,
Sofiane Kab
7
,
Adeline Renuy
7
,
Marie Zins
7
8
,
Karine Lacombe
2
9
,
Lawrence Serfaty
10
11
Affiliations
1
Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA.
2
Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France.
3
Hepatogastroenterology Department, Anger University Hospital, Angers, France.
4
HIFIH Laboratory, UPRES EA3859, SFR 4208, Angers University, Angers, France.
5
Bordeaux University Hospital Branch, Bordeaux, France.
6
Department of Endocrinology-Diabetology, Dijon University Hospital, Dijon, France.
7
Versailles-Saint Quentin University, UMS 11 Inserm, France.
8
Université de Paris, Paris, France.
9
Infectious Diseases Department, Hôpital Saint-Antoine, AP-HP, Paris, France.
10
Hepatogastroenterology Service, Hôpital Hautepierre, Strasbourg University Hospital, France.
11
Sorbonne University, Inserm UMR_S938, Paris, France.
PMID:
38252803
DOI:
10.1097/HEP.0000000000000755
No abstract available
MeSH terms
Body Mass Index
Humans
Liver Function Tests
Non-alcoholic Fatty Liver Disease*